Sexual precocity: A historical perspective and update

Fetal and Pediatric Pathology

Volumn 24, Issue 1, 2005, Pages 39-62

  Root, Allen W ^a,b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b JOHNS HOPKINS ALL CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOPHYSIS HORMONE; HYPOTHALAMUS HORMONE; SEX HORMONE;

AGE; CONGENITAL ADRENAL HYPERPLASIA; EVALUATION; GENE MUTATION; GENETIC REGULATION; GONAD DEVELOPMENT; GONAD TUMOR; GONADOTROPIN SECRETING CELL; HORMONE RELEASE; HUMAN; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; MENARCHE; ONSET AGE; PRECOCIOUS PUBERTY; PRIORITY JOURNAL; REVIEW; SEXUAL MATURATION;

CHILD; FEMALE; HISTORY, 20TH CENTURY; HUMANS; MALE; PUBERTY, PRECOCIOUS; SEXUAL MATURATION;

EID: 22544457238     PISSN: 15513815     EISSN: None     Source Type: Journal    
DOI: 10.1080/15227950590961207     Document Type: Review

References (75)

1. Thamdrup E. Precocious Sexual Development. A Clinical Study of 100 Children. Springfield, IL: Charles C. Thomas, 1961; 1-237.
2. Marti-Henneberg C, Vizmanos B. The duration of puberty in relation to the timing of its onset. J Pediatr 1997;131:618-621.
3. Llop-Vinolas D, Vizmanos B, Closa Monasterolo R, et al. Onset of puberty at eight years of age in girls determines a specific tempo of puberty but does not affect adult height. Acta Paediatr 2004;93:874-879.
4. Herter LD, Golendziner E, Flores JA, et al. Ovarian and uterine findings in pelvic sonography: comparison between prepubertal girls, girls with isolated thelarche, and girls with central precocious puberty. J Ultrasound Med 2002;21:1237-1246.
5. Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child 1970;45:13-23.
6. Marshall WA, Tanner JM. Puberty. In: Falkner F, Tanner JM, eds. Human Growth. A Comprehensive Treatise, Vol. 2, 2nd ed. New York: Plenum Press, 1986:171-209.
7. Anderson SE, Dallal GF, Must A. Relative weight and race influence average age at menarche: results from two nationally representative surveys at of US girls studied 25 years apart. Pediatrics 2003;111:844-850.
8. Parent A-S, Teilmann G, Juul A, et al. The timing of normal puberty and the age limits of sexual precocity: variations around the world, secular trends, and changes after migration. Endocrine Rev 2003;24:668-693.
9. Herman-Giddens PA, Slora EJ, Wasserman RC, et al. Secondary sexual characteristics and menses in young girls seen in office practice: a study from the Pediatric Research in Office Settings Network. Pediatrics 1997;99:505-512.
10. Herman-Giddens PA, Kaplowitz PB, Wasserman R. Navigating the recent articles on girls' puberty in Pediatrics: what do we know and where do we go from here? Pediatrics 2004;113:911-917.
11. Sun SS, Shumei S, Schubert CM, et al. National estimates of the timing of sexual maturation and racial differences among U.S. children. Pediatrics 2002;110:911-919.
12. Wu T, Mendola P, Buck G. Ethnic differences in the presence of secondary sexual characteristics and menarche among U.S. girls: the Third National Health and Nutrition Examination Survey, 1988-1994. Pediatrics 2002;110:752-757.
13. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969;44:291-303.
14. Freedman DS, Khan LK, Serdula MK, et al. Relation of age at menarche to race, time period, and anthropometric dimensions: the Bogalusa heart study. Pediatrics 2002;110(4). URL: http:/www.pediatrics.org/cgi/content/full/110/4/343
15. Herman-Giddens ME, Wang L, Koch G. Secondary sexual characteristics in boys. Estimates from the National Health and Nutrition Examination Survey III, 1988-1994. Arch Pediatr Adolesc Med 2001;155:1022-1028.
16. Sun SS, Schubert CM, Chumlea WC, et al. Lack of evidence that puberty is occurring earlier among U.S. children. Pediatr Res 2004;55:156A.
17. Ibanez L, DiMartino-Nardi J, Potau N, Saenger P. Premature adrenarche - normal variant or forerunner of adult disease. Endocrine Rev 2000;21:671-696.
18. Terasawa E, Fernandez DL. Neurobiological mechanisms of the onset of puberty in primates. Endocrine Rev 2001;22:111-151.
19. Sahu A. Minireview: a hypothalamic role in energy balance with special emphasis on leptin. Endocrinology 2004;145:2613-2620.
20. Kaplowitz P. Precocious puberty: update on secular trends, definitions, diagnosis, and treatment. Adv Pediatr 2004;51:37-62.
21. Welt CK, Chan JL, Bullen J, et al. Recombinant human leptin in women with hypothalamic amenorrhea. N Engl J Med 2004;351:987-997.
22. de Roux N, Genin E, Carel JC, et al. Hypogonadotropic hypogonadism due to loss-of-function of the KISS1-derived peptide receptor GPR54. Proc Natl Acad Sci 2003;100:10972-10976.
23. Seminara SB, Messager S, Chatzidaki E, et al. The GPR54 gene as a regulator of puberty. N Engl J Med 2003;349:1614-1627.
24. Gottsch ML, Cunningham MJ, Smith JT, et al. A role for kisspeptins in the regulation of gonadotropin secretion in the mouse. Endocrinology 2004;145:4073-4077.
25. Navarro VM, Castellano JM, Fernandez-Fernandez R, et al. Characterization of the potent luteinizing hormone releasing activity of KiSS-1 peptide, the natural ligand of GPR54. Endocrinology 2004;146:156-163.
26. Parhar IS, Ogawa S, Sakuma Y. Laser-captured single digoxigenin-labeled neurons of gonadotropin-releasing hormone types reveal a novel G protein-coupled receptor (Gpr54) during maturation in cichlid fish. Endocrinology 2004;145:3616-3618.
27. Rice AM, Rivkees SA. Receptor transduction of hormone action. In: Sperling MA ed. Pediatric Endocrinology, 2nd ed. Philadelphia: W.B. Saunders Co. 2002:33-63.
28. Watson CS, Gametchu B. Proteins of multiple classes may participate in nongenomic steroid actions. Exp Biol Med 2003;228:1271-1281.
29. Wilkins L. Precocious sexual development. In: Wilkins L, ed. The Diagnosis and Treatment of Endocrine Disorders in Childhood and Adolescence, 2nd ed. Springfield, IL: Charles C. Thomas, chapter XI, 1957:198-213.
30. de Vries L, Kauschansky A, Shohat M, Phillip M. Familial central precocious puberty suggests autosomal dominant inheritance. J Clin Endocrinol Metab 2004;89:1794-1800.
31. Jung H, Probst EN, Hauffa BP, et al. Association of morphological characteristics with precocious puberty and/or gelastic seizures in hypothalamic hamartoma. J Clin Endocrinol Metab 2003;88:4590-4595.
32. Bona G, Marinello D. Precocious puberty in immigrant children: indications for treatment. J Pediatr Endocrinol Metab 2000;13:831-834.
33. Kalantaridou SN, Chrousos GP. Monogenic disorders of puberty. J Clin Endocrinol Metab 2002;87:2481-2494.
34. Lumbroso S, Paris F, Sultan C. Activating Gsα mutations: analysis of 113 patients with signs of McCune-Albright syndrome - a European collaborative study. J Clin Endocrinol Metab 2004;89:2107-2113.
35. Roman R, Johnson MC, Codner E, et al. Activating GNAS1 gene mutations in patients with premature thelarche. J Pediatr 2004;145:218-222.
36. Shozu M, Sebastian S, Takayama K, et al. Estrogen excess associated with novel gain-of-function mutations affecting the aromatase gene. N Engl J Med 2003;348:1855-1865.
37. Speiser PW, White PC. Congenital adrenal hyperplasia. N Engl J Med 2003;349:776-788.
38. Draper N, Walker EA, Bujalska IJ, et al. Mutations in the genes encoding 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency. Nature Genet 2003;34:434-439.
39. Malunowicz EM, Romer TE, Urban M, Bossowski A. 11 Beta-hydroxysteroid dehydrogenase type 1 deficiency ('apparent cortisone reductase deficiency') in a 6-year-old boy. Horm Res 2003;59:205-210.
40. Tomlinson JW, Walker EA, Bujalska IJ, et al. 11β-Hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocrine Rev 2004;25:831-866.
41. Malchoff DM, Brufsky BA, Reardon G, et al. A mutation of the glucocorticoid receptor in primary cortisol resistance. J Clin Invest 1993;91:1918-1925.
42. Kunz GJ, Klein KO, Clemmons RD, et al. Virilization of young children after topical androgen use by their parents. Pediatrics 2004;114:282-284.
43. Greim HA. The endocrine and reproductive system: adverse effects of hormonally active substances. Pediatrics 2004;113:1070-1075.
44. Lorraine JA, Bell ET. Estrogens. Hormone Assays and Their Clinical Application, Baltimore: William & Wilkins, chapter X, 1966:226-301.
45. Neeley EK, Wilson DM, Lee PA, et al. Spontaneous serum gonadotropin concentrations in the evaluation of precocious puberty. J Pediatr 1995;127:47-52.
46. Chalumeau M, Chemaitilly W, Trivin C, et al. Central precocious puberty in girls: an evidence-based diagnosis tree to predict central nervous system abnormalities. Pediatrics 2002;109:61-67.
47. Ng SM, Kumar Y, Cody D, et al. Cranial MRI scans are indicated in all girls with central precocious puberty. Arch Dis Child 2003;88:414-417.
48. Ritzen EM. Early puberty: what is normal and when is treatment indicated? Horm Res 2003;60(suppl 3):31-34.
49. Weise M, Flor A, Barnes KM, et al. Determinants of growth during gonadotropin-releasing hormone analog therapy for precocious puberty. J Clin Endocrinol Metab 2004;89:103-107.
50. Lee PA. Medroxyprogesterone therapy for sexual precocity in girls. Am J Dis Child 1981;135: 443-445.
51. Paul D, Conte FA, Grumbach MM, Kaplan SL. Long term effect of gonadotropin-releasing hormone agonist therapy on final and near-final height in 26 children with true precocious puberty treated at a median age of less than five years. J Clin Endocrinol Metab 1995;80:546-551.
52. Belchetz PE, Plant TM, Nakai Y, et al. Hypophysial responses to continuous and intermittent delivery of hypothalamic gonadotropin-releasing hormone. Science 1978;202:631-633.
53. Comite F, Cutler GB Jr, Rivier J, et al. Short-term treatment of idiopathic precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. N Engl J Med 1981;305: 1546-1550.
54. Kappy MS, Ganong CS. Advances in treatment of precocious puberty. Adv Pediatr 1994;41:223-261.
55. Klein K, Barnes KM, Jones JV, et al. Increased final height in precocious puberty after long-term treatment with LHRH agonists: the National Institutes of Health experience. J Clin Endocrinol Metab 2001;86:4711-4716.
56. Mul D, Bertelloni S, Carel JC, et al. Effect of gonadotropin releasing hormone agonist treatment in boys with central precocious puberty: final height results. Horm Res 2002;58:1-7.
57. Huirne JAF, Lambalk CB. Gonadotropin-releasing-hormone-receptor antagonists. Lancet 2001;358:1793-1803.
58. Pucarelli I, Segni M, Ortore M, et al. Effects of combined gonadotropin-releasing hormone agonist and growth hormone therapy on adult height in precocious puberty: a further contribution. J Pediatr Endocrinol Metab 2003;16:1005-1010.
59. Feuillan PP, Jones JV, Barnes K, et al. Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with central precocious puberty: long term follow-up comparing girls with hypothalamic hamartomas to those with idiopathic precocious puberty. J Clin Endocrinol Metab 1999;84:44-49.
60. Baumann DA, Landolt MA, Wetterwald R, et al. Psychological evaluation of young women after medical treatment for central precocious puberty. Horm Res 2001;56:45-50.
61. Bouvattier C, Coste J, Rodriguez D, et al. Lack of effect of GnRH agonists on final height in girls with advanced puberty: a randomized long-term pilot study. J Clin Endocrinol Metab 1999;84:3575-3578.
62. Cassio A, Cacciari E, Balsamo A, et al. Randomised trial of LHRH analogue treatment on final height in girls with onset of puberty aged 7.5-8.5 years. Arch Dis Child 1992;81:329-332.
63. Palmert MR, Malin HV, Boepple PA. Unsustained or slowly progressive puberty in young girls: initial presentation and long-term follow-up of 20 untreated patients. J Clin Endocrinol Metab 1999;84:415-423.
64. Wacharasindhu S, Srivuthana S, Aroonparkmongkol S, et al. Final adult height in "early normal pubertal girls" treated with gonadotropin releasing hormone agonists. J Med Assoc Thai 2003;86(Suppl 2):S170-S173.
65. Officioso A, Salerno M, Lettiero T, et al. Adolescent girls with idiopathic central precocious puberty: typical character traits. J Pediatr Endocrinol Metab 2000;13:835-839.
66. Graber JA, Seeley JR, Brooks-Gunn J, Lewinsohn PM. Is pubertal timing associated with psychopathology in young adulthood? J Am Acad Child Adolesc Psychiatry 2004;43:718-726.
67. Stice E, Presnell K, Bearman SK. Relation of early menarche to depression, eating disorders, substance abuse, and comorbid psychopathology among adolescent girls. Devel Psychol 1991;37: 608-619.
68. Ellis BJ, Garber J. Psychosocial antecedents of variations in girls' pubertal timing: maternal depression, stepfather, and marital and family stress. Child Devel 2000;71:485-501.
69. Eugster EA, Rubin SD, Reiter EO, et al. Tamoxifen treatment for precocious puberty in McCune-Albright syndrome: a multicenter trial. J Pediatr 2003;143:60-66.
70. Lee PA. Normal ages of pubertal events among American males and females. J Adolesc Health Care 1980;1:26-29.
71. Lee PA. Puberty and its disorders. In: Lifshitz F, ed. Pediatric Endocrinology, 4th ed., New York: Marcel Dekker, 2003:211-238.
72. Achermann JC, Ozisik O, Meeks JJ, Jameson JL. Genetic causes of human reproductive disease. J Clin Endocrinol Metab 2002;87:2447-2454.
73. Cohen LE, Radovick S. Molecular basis of combined pituitary deficiencies. Endocrine Rev 2002;23:431-442.
74. Rosenfield RL. Selection of children with precocious puberty for treatment with gonadotropin releasing hormone analogs. J Pediatr 1994;124:989-991.
75. Cone RD, Low MJ, Elmquist JK, Cameron JL. Neuroendocrinology. In: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS, eds. Williams Textbook of Endocrinology, 10th ed. Philadelphia: W.B. Saunders, chapter 7, 2003:81-176.